Eli Lilly shares promising phase 3 results for once-weekly insulin efsitora in type 2 diabetes
It is hoped that a once-weekly treatment option could lead to improved adherence
Source: pmlive.com
Jeff Emmick News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jeff Emmick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jeff Emmick Today - Breaking & Trending Today
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-2 and QWINT-4 phase 3 clinical trials evaluating...
Source: prnewswire.com
Eli Lilly: positive trials in type 2 diabetes
Eli Lilly announced today the first positive results of two Phase 3 clinical trials evaluating the once-weekly insulin efsitora alfa in adults with type 2 diabetes using insulin for the first time,...
Source: marketscreener.com
Eli Lilly says experimental weekly insulin works as well as dailies
The pharma giant known for its diabetes and weight loss medications shared results of a late-stage clinical trrial for its long-acting insulin
Source: qz.com